Investor relations activity record form of Zhejiang Huakang Pharmaceutical Co., Ltd. 2024-002
Announcement of Huakang Co., Ltd. on receiving dividends from wholly-owned subsidiaries
Huakang Co., Ltd. 2023 Equity Distribution Implementation Notice
Announcement of Huakang Co., Ltd. on adjusting the conversion price of “Huakang Bonds” due to the implementation of equity distribution
Huakang Co., Ltd.'s progress announcement on the use of some idle funds raised for cash management
Announcement of Huakang Co., Ltd. on holding a performance briefing for the first quarter of 2023 and 2024
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Huakang Co.
Legal Opinion of Guohao Lawyers (Hangzhou) Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Huakang Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 13th Meeting of the 6th Board of Supervisors of Huakang Co., Ltd
Huakang Co., Ltd. Accounting Services Selection and Employment System
Announcement of Huakang Co., Ltd. on the main operating data for the first quarter of 2024
Huakang Co., Ltd. 2024 First Quarter Report
Announcement of Resolutions of the 16th Meeting of the 6th Board of Directors of Huakang Co., Ltd.
Materials of the 2023 Annual General Meeting of Shareholders of Huakang Co., Ltd.
Announcement of Resolutions of the 15th Meeting of the 6th Board of Directors of Huakang Co., Ltd.
Resolutions of the first special meeting of independent directors of the 6th board of directors of Huakang Co., Ltd.
Report on the performance of the Audit Committee of the Board of Directors of Huakang Co., Ltd. in 2023
Report of Huakang Co., Ltd. on the performance of supervisory duties by the board audit committee on the company's audit institutions in 2023
Huakang Co., Ltd.'s assessment report on the performance of accounting firms in 2023
Announcement of Huakang Co., Ltd. on the main operating data for 2023
No Data